{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:37:23Z","timestamp":1770039443428,"version":"3.49.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.2169\/internalmedicine.2427-23","type":"journal-article","created":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T22:15:52Z","timestamp":1699827352000},"page":"1719-1723","source":"Crossref","is-referenced-by-count":4,"title":["Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome"],"prefix":"10.2169","volume":"63","author":[{"given":"Kento","family":"Shionoya","sequence":"first","affiliation":[{"name":"Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kako","sequence":"additional","affiliation":[{"name":"Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakue","family":"Masuda","sequence":"additional","affiliation":[{"name":"Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makomo","family":"Makazu","sequence":"additional","affiliation":[{"name":"Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Reau NS, Jensen DM. Vanishing bile duct syndrome. Clin Liver Dis 12: 203-217, 2008.","DOI":"10.1016\/j.cld.2007.11.007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ludwig J, Wiesner RH, LaRusso NF. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 7: 193-199, 1988.","DOI":"10.1016\/S0168-8278(88)80482-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakanuma Y, Tsuneyama K, Harada K. Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobil Pancreat Surg 8: 303-315, 2001.","DOI":"10.1007\/s005340170002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Takikawa H, Onji M. A proposal of the diagnostic scale of drug-induced liver injury. Hepatol Res 32: 250-251, 2005.","DOI":"10.1016\/j.hepres.2005.05.007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Anugwom C, Goetz G, Hassan M. Vanishing bile duct syndrome preceding the diagnosis of Hodgkin lymphoma. ACG Case Rep J 7: e00336, 2020.","DOI":"10.14309\/crj.0000000000000336"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kita H, Matsumura S, He XS, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109: 1231-1240, 2002.","DOI":"10.1172\/JCI0214698"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Okan G, Yaylaci S, Peker O, Kaymakoglu S, Saruc M. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol 14: 4697-4700, 2008.","DOI":"10.3748\/wjg.14.4697"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Tajiri H, Etani Y, Mushiake S, Ozono K, Nakayama M. A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder. J Paediatr Child Health 44: 234-236, 2008.","DOI":"10.1111\/j.1440-1754.2008.01291.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid &quot;mechanisms of action and clinical use in hepatobiliary disorders&quot; . J Hepatol 35: 134-146, 2001.","DOI":"10.1016\/S0168-8278(01)00092-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Smith LA, Ignacio JR, Winesett MP, et al. Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intrahepatic cholestasis responsive to ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 41: 469-473, 2005.","DOI":"10.1097\/01.mpg.0000178086.44155.73"},{"key":"11","unstructured":"11. Rios R, Herrero JI, Quiroga J, et al. Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation. Dig Dis Sci 46: 1420-1423, 2001."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Karnsakul W, Arkachaisri T, Atisook K, Wisuthsarewong W, Sattawatthamrong Y, Aanpreung P. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms. Ann Hepatol 5: 116-119, 2006.","DOI":"10.1016\/S1665-2681(19)32029-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Srivastava M, Perez-Atayde A, Jonas MM. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology 115: 743-746, 1998.","DOI":"10.1016\/S0016-5085(98)70154-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Juricic D, Hrstic I, Radic D, et al. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man. Basic Clin Pharmacol Toxicol 106: 62-65, 2010.","DOI":"10.1111\/j.1742-7843.2009.00474.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Taghian M, Tran TA, Bresson-Hadni S, Menget A, Felix S, Jacquemin E. Acute vanishing bile duct syndrome after ibuprofen therapy in a child. J Pediatr 145: 273-276, 2004.","DOI":"10.1016\/j.jpeds.2004.05.027"},{"key":"16","unstructured":"16. Alam I, Ferrell LD, Bass NM. Vanishing bile duct syndrome temporally associated with ibuprofen use. Am J Gastroenterol 91: 1626-1630, 1996."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. El Hajj II, Malik SM, Alwakeel HR, Shaikh OS, Sasatomi E, Kandil HM. Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation. World J Gastroenterol 15: 3937-3939, 2009.","DOI":"10.3748\/wjg.15.3937"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. O&apos;Beirne JP, Cairns SR. Drug points: cholestatic hepatitis in association with celecoxib. BMJ 323: 23, 2001.","DOI":"10.1136\/bmj.323.7303.23"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Galan MV, Gordon SC, Silverman AL. Celecoxib-induced cholestatic hepatitis. Ann Intern Med 134: 254, 2001.","DOI":"10.7326\/0003-4819-134-3-200102060-00028"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Grieco A, Miele L, Giorgi A, Civello IM, Gasbarrini G. Acute cholestatic hepatitis associated with celecoxib. Ann Pharmacother 36: 1887-1889, 2002.","DOI":"10.1345\/1542-6270(2002)036<1887:ACHAWC>2.0.CO;2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Alegria P, Lebre L, Chagas C. Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis. Ann Intern Med 137: 75, 2002.","DOI":"10.7326\/0003-4819-137-1-200207020-00030"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2427-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:29:25Z","timestamp":1718422165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2427-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2427-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"article-number":"2427-23"}}